These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Testosterone replacement in men. Beg S; Al-Khoury L; Cunningham GR Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278 [TBL] [Abstract][Full Text] [Related]
7. [Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men]. Asscheman H; Gooren LJ Ned Tijdschr Geneeskd; 2000 Apr; 144(18):847-50. PubMed ID: 10816775 [TBL] [Abstract][Full Text] [Related]
8. Hormonal therapy of male hypogonadism. Matsumoto AM Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324 [TBL] [Abstract][Full Text] [Related]
9. Testosterone administration in older men. Matsumoto AM Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401 [TBL] [Abstract][Full Text] [Related]
10. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. Iglesias P; Carrero JJ; Díez JJ J Nephrol; 2012; 25(1):31-42. PubMed ID: 21748720 [TBL] [Abstract][Full Text] [Related]
11. The effects of pharmacologically induced hypogonadism on mood in healthy men. Schmidt PJ; Berlin KL; Danaceau MA; Neeren A; Haq NA; Roca CA; Rubinow DR Arch Gen Psychiatry; 2004 Oct; 61(10):997-1004. PubMed ID: 15466673 [TBL] [Abstract][Full Text] [Related]
12. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy. Abrams D AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352 [TBL] [Abstract][Full Text] [Related]
13. Testosterone and men's quality of life. Moncada I Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553 [TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratoristic strategy in late onset hypogonadism. Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196 [TBL] [Abstract][Full Text] [Related]
15. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men. Behre HM; Heinemann L; Morales A; Pexman-Fieth C Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063 [TBL] [Abstract][Full Text] [Related]
16. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel. Swerdloff RS; Wang C Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501 [TBL] [Abstract][Full Text] [Related]
17. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations. Morales A; Black AM; Emerson LE BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790 [TBL] [Abstract][Full Text] [Related]
18. Testosterone supplementation: what and how to give. Jockenhövel F Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500 [TBL] [Abstract][Full Text] [Related]
19. Outcomes associated with hypogonadism in men with chronic kidney disease. Palmer BF Adv Chronic Kidney Dis; 2004 Oct; 11(4):342-7. PubMed ID: 15492970 [TBL] [Abstract][Full Text] [Related]
20. Testosterone therapy: treatment of metabolic disturbances in heart failure. Naghi JJ; Philip KJ; DiLibero D; Willix R; Schwarz ER J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):14-23. PubMed ID: 21097668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]